InvestorWire NewsRoom

InvestorNewsBreak

InvestorNewsBreaks – Cannabis Global Inc. (CBGL) Announces Research Partnership to Develop Cannabinoid Infusion Techniques
October 27, 2020

InvestorNewsBreaks – Cannabis Global Inc. (CBGL) Announces Research Partnership to Develop Cannabinoid Infusion Techniques

Cannabis Global (OTC: CBGL), a cannabinoid and hemp-extract, science-forward company developing infusion and delivery technologies, has formed a key research relationship with Marijuana Company of America Inc. (OTC: MCOA). MCOA joins the Project Varin research and development program, along with already existing partner Natural Plant Extract of California Inc. (“NPE”). The companies are collaborating on the development of new protocols and techniques for food and beverage cannabinoid infusion. Recently the program has created highly loaded cannabinoid nano units made from all-natural ingredients. These nano units will allow product formulators to create foods and beverages with clean labels and without bitter tastes. This new approach also allows manufacturers to use fewer active ingredients, which may reduce costs, or utilize the full amount of an active ingredient to obtain a superior effect. “Marijuana Company of America and Cannabis Global are both equity holders in NPE, which holds both manufacturing and distribution licenses within the State of California, so this collaboration between the three companies is a natural fit,” said Cannabis Global CEO Arman Tabatabaei in the press release. “Upon the filing of our next patent in this area, we plan to jointly work within the California regulatory framework to create a new method to infuse food and beverages with THC. The technology holds the promise to rewrite the industry dynamic relative to both cost of infusion and overall efficacy for not only THC, but also for other cannabinoids.”

To view the full press release, visit https://ibn.fm/g0uCi

About Cannabis Global Inc.

Cannabis Global, formerly known as MCTC Holdings Inc., is a fully audited and reporting company with the U.S. Securities & Exchange Commission. The company is an emerging force in the area of cannabinoid sciences and highly bioavailable hemp- and cannabis-infusion technologies. The company does not engage in the production, distribution or sales of any controlled substances, including marijuana. CBGL has an actively growing portfolio of intellectual property, having filed six patents in the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles. The company markets its consumer products under the Hemp You Can Feel brand name. Cannabis Global launched its Project Varin early in 2020, designed to develop new delivery methods for rare cannabinoid tetrahydrocannabivarin (“THV-C”) and to develop products based on this cannabinoid. For more information about the company, visit www.CannabisGlobalInc.com.

NOTE TO INVESTORS: The latest news and updates relating to CBGL are available in the company’s newsroom at http://ibn.fm/CBGL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Recent NewsBreaks

NewsBreaks Categories

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).